RESDS希土類SDSライブラリ
English
01 / 安全データシート

Gadoteridol SDS

Original MedChemExpress safety data sheet for Gadoteridol. 原本PDF retained without modification. 情報源 collected on 2026-09-13.

02 / ORIGINAL PDF

PDFプレビュー

無料で閲覧・ダウンロード可能・登録やログインは不要です。

PDFを読み込み中…

First page preview
03 / RESDS DATA ANALYSIS

Normalized SDS data & document analysis

RESDS derives the results below from this document’s extracted text and the site’s same-material index. Detected codes are not reclassified. “Not detected” does not mean “not present”; confirm the original PDF for safety-critical use.

SDS sections16/16
Coverage100%
Hazard codes0
Precautionary codes0
UN numbers0
Same-material docs4

SDS 16-section coverage

16 section headings detected; 0 not detected by the parser.

1. Identification · detected2. Hazard identification · detected3. 組成 / ingredients · detected4. First-aid measures · detected5. Fire-fighting measures · detected6. Accidental release measures · detected7. Handling and storage · detected8. Exposure controls / PPE · detected9. Physical and chemical properties · detected10. Stability and reactivity · detected11. Toxicological information · detected12. Ecological information · detected13. Disposal considerations · detected14. Transport information · detected15. Regulatory information · detected16. Other information · detected

Same-material SDS comparison

4 indexed 件の文書 · 4 publishers · 1 languages · 2 stated revisions · page range 6–7. This compares document metadata, not product equivalence.

発行元改訂版言語国・地域ページ数
Current MedChemExpress記載なし英語記載なし6
APExBIO記載なし英語記載なし7
Cayman Chemical11/05/2025英語米国 · OSHA7
Sigma-Aldrich03/03/2018 · Version 5.1英語記載なし6
SDS publisher documentEXTRACTED RESDS parserCALCULATED deterministic conversion / coverageDERIVED same-material index comparison
04 / SPECIFICATIONS

材料・文書仕様

Material
Gadoteridol
製品・グレード
記載なし
発行元
MedChemExpress
国・地域
記載なし
ファイル名
135_Gadoteridol_MedChemExpress_EN.pdf
文書の種類
SDS
CAS登録番号
120066-54-8
言語
英語
原本改訂日
記載なし
ページ数
6
ファイルサイズ
252 KB
ダウンロード数
4
追加日
2026-09-13
GdOrganic / coordination complex
この文書が該当する理由

完全一致は記載された物質組成に基づきます。微量不純物は除外されません。

C · Composition · ページ 1
Formula: C17H28GdN4O7
H · Composition · ページ 1
Formula: C17H28GdN4O7
Gd · Composition · ページ 1
Formula: C17H28GdN4O7
N · Composition · ページ 1
Formula: C17H28GdN4O7
O · Composition · ページ 1
Formula: C17H28GdN4O7

その他の記載元素: C, H, N, O

05 / DOCUMENT TEXT

Full document text

6ページ · 原文書の言語

Text extracted from the original PDF. ページ order and original wording are preserved; tables and symbols may differ from the PDF layout. Check the original PDF for safety-critical details.

ページ 1

安全データシート Inhibitors

改訂版 Date: Nov.-6-2023 • Print Date: Oct.-15-2025

1. PRODUCT AND COMPANY IDENTIFICATION Screening

1.1 Product identifier

製品名 : Gadoteridol Libraries Catalog No. : HY-B0933 CAS No. : 120066-54-8 •

1.2 Relevant identified uses of the substance or mixture and uses advised against

Identified uses : Laboratory chemicals, manufacture of substances. Proteins 1.3 詳細 of the supplier of the safety data sheet

Company: MedChemExpress USA

Tel: 609-228-6898

Fax: 609-228-5909

E-mail: sales@medchemexpress.com

1.4 Emergency telephone number

Emergency 電話番号 #: 609-228-6898

2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture

Not a hazardous substance or mixture.

2.2 GHS Label elements, including precautionary statements

Not a hazardous substance or mixture.

2.3 Other hazards

None.

3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances

別名: SQ-32692; Gd-HP-DO3A

Formula: C17H28GdN4O7

Molecular Weight: 557.68

CAS No. : 120066-54-8

4. FIRST AID MEASURES

4.1 説明 of first aid measures

Eye contact

Remove any contact lenses, locate eye-wash station, and flush eyes immediately with large amounts of water. Separate eyelids

with fingers to ensure adequate flushing. Promptly call a physician.

Skin contact

ページ 1 of 6 www.MedChemExpress.com

ページ 2

Rinse skin thoroughly with large amounts of water. Remove contaminated clothing and shoes and call a physician.

Inhalation

Immediately relocate self or casualty to fresh air. If breathing is difficult, give cardiopulmonary resuscitation (CPR). Avoid mouth-

to-mouth resuscitation.

Ingestion

Wash out mouth with water; Do NOT induce vomiting; call a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section 2.2).

4.3 Indication of any immediate medical attention and special treatment needed

Treat symptomatically.

5. FIRE FIGHTING MEASURES

5.1 Extinguishing media

Suitable extinguishing media

Use water spray, dry chemical, foam, and carbon dioxide fire extinguisher.

5.2 Special hazards arising from the substance or mixture

During combustion, may emit irritant fumes.

5.3 Advice for firefighters

Wear self-contained breathing apparatus and protective clothing.

6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

Use full personal protective equipment. Avoid breathing vapors, mist, dust or gas. Ensure adequate ventilation. Evacuate

personnel to safe areas.

Refer to protective measures listed in sections 8.

6.2 Environmental precautions

Try to prevent further leakage or spillage. Keep the product away from drains or water courses.

6.3 Methods and materials for containment and cleaning up

Absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); Decontaminate surfaces and

equipment by scrubbing with alcohol; Dispose of contaminated material according to Section 13.

6.4 Reference to other sections

For disposal see section 13.

7. HANDLING AND STORAGE

7.1 Precautions for safe handling

Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust

ventilation.

7.2 Conditions for safe storage, including any incompatibilities

Keep container tightly sealed in cool, well-ventilated area. Keep away from direct sunlight and sources of ignition.

おすすめ storage temperature: Powder -20°C 3 years

4°C 2 years

ページ 2 of 6 www.MedChemExpress.com

ページ 3

In solvent -80°C 6 months

-20°C 1 month Shipping at room temperature if less than 2 weeks.

7.3 Specific end use(s)

No data available.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters

Components with workplace control parameters

This product contains no substances with occupational exposure limit values.

8.2 Exposure controls

Engineering controls

Ensure adequate ventilation. Provide accessible safety shower and eye wash station.

Personal protective equipment

Eye protection Safety goggles with side-shields.

Hand protection Protective gloves.

Skin and body protection Impervious clothing.

Respiratory protection Suitable respirator.

Environmental exposure controls Keep the product away from drains, water courses or the soil. Clean

spillages in a safe way as soon as possible.

9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

Appearance Solid

Odor No data available

Odor threshold No data available

pH No data available

Melting/freezing point 188-193°C

Boiling point/range No data available

Flash point No data available

Evaporation rate No data available

Flammability (solid, gas) No data available

Upper/lower flammability or explosive limits No data available

Vapor pressure No data available

Vapor density No data available

Relative density No data available

Water Solubility No data available

Partition coefficient No data available

Auto-ignition temperature No data available

Decomposition temperature No data available

Viscosity No data available

Explosive properties No data available

ページ 3 of 6 www.MedChemExpress.com

ページ 4

Oxidizing properties No data available

9.2 Other safety information

No data available.

10. STABILITY AND REACTIVITY

10.1 Reactivity

No data available.

10.2 Chemical stability

Stable under recommended storage conditions.

10.3 Possibility of hazardous reactions

No data available.

10.4 Conditions to avoid

No data available.

10.5 Incompatible materials

Strong acids/alkalis, strong oxidising/reducing agents.

10.6 Hazardous decomposition products

Under fire conditions, may decompose and emit toxic fumes.

Other decomposition products - no data available.

11.TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects

Acute toxicity

Classified based on available data. For more details, see section 2

Skin corrosion/irritation

Classified based on available data. For more details, see section 2

Serious eye damage/irritation

Classified based on available data. For more details, see section 2

Respiratory or skin sensitization

Classified based on available data. For more details, see section 2

Germ cell mutagenicity

Classified based on available data. For more details, see section 2

Carcinogenicity

IARC: No component of this product present at a level equal to or greater than 0.1% is identified as probable, possible or

confirmed human carcinogen by IARC.

ACGIH: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed

carcinogen by ACGIH.

NTP: No component of this product present at a level equal to or greater than 0.1% is identified as a anticipated or confirmed

carcinogen by NTP.

OSHA: No component of this product present at a level equal to or greater than 0.1% is identified as a potential or confirmed

carcinogen by OSHA.

Reproductive toxicity

ページ 4 of 6 www.MedChemExpress.com

ページ 5

Classified based on available data. For more details, see section 2

Specific target organ toxicity - single exposure

Classified based on available data. For more details, see section 2

Specific target organ toxicity - repeated exposure

Classified based on available data. For more details, see section 2

Aspiration hazard

Classified based on available data. For more details, see section 2

Additional information

This information is based on our current knowledge. However the chemical, physical, and toxicological properties have not been

completely investigated.

12. ECOLOGICAL INFORMATION

12.1 Toxicity

No data available.

12.2 Persistence and degradability

No data available.

12.3 Bioaccumlative potential

No data available.

12.4 Mobility in soil

No data available.

12.5 検索結果 of PBT and vPvB assessment

PBT/vPvB assessment unavailable as chemical safety assessment not required or not conducted.

12.6 Other adverse effects

No data available.

13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

Dispose substance in accordance with prevailing country, federal, state and local regulations.

Contaminated packaging

Conduct recycling or disposal in accordance with prevailing country, federal, state and local regulations.

14. TRANSPORT INFORMATION

DOT (US)

Proper shipping name: Not dangerous goods

UN number: -

Class: -

Packing group: -

IMDG

Proper shipping name: Not dangerous goods

ページ 5 of 6 www.MedChemExpress.com

ページ 6

UN number: -

Class: -

Packing group: -

IATA

Proper shipping name: Not dangerous goods

UN number: -

Class: -

Packing group: -

15. REGULATORY INFORMATION

SARA 302 Components:

No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.

SARA 313 Components:

This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis)

reporting levels established by SARA Title III, Section 313.

SARA 311/312 Hazards:

No SARA Hazards.

Massachusetts Right To Know Components:

No components are subject to the Massachusetts Right to Know Act.

Pennsylvania Right To Know Components:

No components are subject to the Pennsylvania Right to Know Act.

New Jersey Right To Know Components:

No components are subject to the New Jersey Right to Know Act.

California Prop. 65 Components:

This product does not contain any chemicals known to State of California to cause cancer, birth defects, or anyother reproductive

harm.

16. OTHER INFORMATION

Copyright 2025 MedChemExpress. The above information is correct to the best of our present knowledge but does not purport to

be all inclusive and should be used only as a guide. The product is for research use only and for experienced personnel. It must

only be handled by suitably qualified experienced scientists in appropriately equipped and authorized facilities. The burden of

safe use of this material rests entirely with the user. MedChemExpress disclaims all liability for any damage resulting from

handling or from contact with this product.

Caution: Product has not been fully validated for medical applications. For research use only.

Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@MedChemExpress.com

住所: 1 Deer Park Dr, Suite F, Monmouth Junction, NJ 08852, USA

ページ 6 of 6 www.MedChemExpress.com

06 / OTHER 発行元S

同一材料:他の発行元によるSDS

3 件の文書がこの材料索引にあります。製品グレード、水和状態、配合は各原本PDFで確認してください。

07 / SOURCE COMPANY

原発行元・企業情報

供給元 / publisher listed in SDS

MedChemExpress USA

登録上の発行元: MedChemExpress

公式サイト確認済み
ブランド・組織
MedChemExpress (MCE)
国・地域/事業所
米国
ウェブサイト
medchemexpress.com
SDS記載の連絡先メール
sales@medchemexpress.com
SDS記載の電話番号
609-228-6898
製品・参照番号
Gadoteridol
公式ウェブサイトの連絡先sales@medchemexpress.com (Sales / customer service)情報源 · 確認日: 2026-09-14

Official MedChemExpress contact page verifies the U.S. headquarters, company name and sales/customer-service email.

抽出した供給元情報を表示
Details of the supplier of the safety data sheet

   Company:                     MedChemExpress USA

    Tel:                              609-228-6898

    Fax:                             609-228-5909

    E-mail:                        sales@medchemexpress.com

RESDSについて MedChemExpress USA

Official MedChemExpress contact page verifies the U.S. headquarters, company name and sales/customer-service email.

Company website & profile
文書の出典・収録履歴

原登録: Gadoteridol — 安全データシート — MedChemExpress

追加日: 2026-09-13T12:49:04.000Z · 登録更新: 2026-09-14T04:27:05.267Z

原本ファイル SHA-256: 168c476c2560cc87bc5743ebb32be3619ebfbd55af220cb9cfddcc24084ed64a

原典PDF

訂正・文書更新を依頼

メタデータの誤り、抽出エラー、供給元による新版、権利上の問題を報告できます。報告内容は運営者が確認するため非公開で保存され、送信しただけで公開中のSDSが直ちに変更されることはありません。

報告内容と任意のメールアドレスは、対応のため非公開で保存されます。サイト上には公開されません。機密情報や個人の重要情報を入力しないでください。

08 / OFFICIAL REFERENCES

公式化学物質情報源

情報源ガイド ↗

このSDSに記載されたCAS番号です。以下の性質は個々の物質に関するもので、製品全体を示すとは限りません。混合物、グレード、水和状態については原本SDSをご確認ください。

CAS 120066-54-8化学物質の参考情報・情報源リンク
化学物質名(IUPAC)
PubChemで確認 ↗

この参考リンクを開くと、PubChemで公開されている物性情報を取得できます。公式検索リンクは引き続き利用できます。

GHSは分類基準を示すものです。適用される危険有害性分類は、対象製品および各法域について個別に確認してください。

09 / 材料名 SUPPLIERS

この材料の供給元

該当材料のSDSと公式製品ページから確認した企業です。グレード、組成、供給状況は供給元へ直接ご確認ください。確認できない連絡先は推測して掲載しません。

Company国・地域ウェブサイトメール電話番号Evidence
APExBIO記載なしウェブサイト sales@apexbt.com記載なし情報源 Same material SDS; verify grade and availability
Cayman Chemical Co.米国ウェブサイト 記載なし記載なし情報源 Same material SDS; verify grade and availability
Sigma-Aldrich米国ウェブサイト 記載なし+1 800-325-5832情報源 Same material SDS; verify grade and availability
ウェブでその他の供給元を検索
10 / GLOBAL SEARCH

この材料を複数の検索エンジンで検索

検索語: Gadoteridol SDS

11 / WIKIPEDIA

Wikipediaによる材料の基礎情報

Wikipediaで Gadoteridol を検索します。該当記事がある場合は概要を表示します。製品固有の混合物や標準物質には専用記事がない場合があります。

Wikipediaでこの材料を検索 ↗

Access logs & privacy